uveitis going strong today
November 5, 2026 at 12:04 AM
uveitis going strong today
My uveitis flared this week.
Saw my optician Friday.
App't made with my eye Consultant at the hospital today.
Allan, my first eye implant has run out.
So on Thursday I'm getting implants in BOTH eyes.
Some pain, then 12 hours of pretty bad pain, then 3 months of clearish vision.
Bravo Scottish NHS.
Saw my optician Friday.
App't made with my eye Consultant at the hospital today.
Allan, my first eye implant has run out.
So on Thursday I'm getting implants in BOTH eyes.
Some pain, then 12 hours of pretty bad pain, then 3 months of clearish vision.
Bravo Scottish NHS.
November 2, 2026 at 2:15 PM
My uveitis flared this week.
Saw my optician Friday.
App't made with my eye Consultant at the hospital today.
Allan, my first eye implant has run out.
So on Thursday I'm getting implants in BOTH eyes.
Some pain, then 12 hours of pretty bad pain, then 3 months of clearish vision.
Bravo Scottish NHS.
Saw my optician Friday.
App't made with my eye Consultant at the hospital today.
Allan, my first eye implant has run out.
So on Thursday I'm getting implants in BOTH eyes.
Some pain, then 12 hours of pretty bad pain, then 3 months of clearish vision.
Bravo Scottish NHS.
Ophthopedia Update: Correlation of initial treatment with time to resolution of HLA-B27-associated acute anterior uveitis: Evaluate the treatment outcomes of oral prednisone in HLA-B27-associated acute anterior uveitis (AAU). #Ophthalmology #Ophthotwitter #Scicomm
Correlation of initial treatment with time to resolution of HLA-B27-associated acute anterior uveitis
Evaluate the treatment outcomes of oral prednisone in HLA-B27-associated acute anterior uveitis (AAU).
dlvr.it
November 2, 2026 at 10:16 AM
Ophthopedia Update: Correlation of initial treatment with time to resolution of HLA-B27-associated acute anterior uveitis: Evaluate the treatment outcomes of oral prednisone in HLA-B27-associated acute anterior uveitis (AAU). #Ophthalmology #Ophthotwitter #Scicomm
Ophthopedia Update: A Quiet Masquerader: Ocular Siderosis Mimicking Chronic Uveitis and Retinal Detachment: .
A Quiet Masquerader: Ocular Siderosis Mimicking Chronic Uveitis and Retinal Detachment
.
dlvr.it
November 1, 2026 at 7:29 PM
Ophthopedia Update: A Quiet Masquerader: Ocular Siderosis Mimicking Chronic Uveitis and Retinal Detachment: .
Going for more blood work and x rays. Her intern was pretty sure it is psoriatic arthritis but the doctor wasn’t having it. I know there is something wrong with me. She said “ well I can give you drugs if that’s what you want” but it’s not what I want. Said the scleritis and uveitis could be a fluke
November 3, 2026 at 4:42 PM
Going for more blood work and x rays. Her intern was pretty sure it is psoriatic arthritis but the doctor wasn’t having it. I know there is something wrong with me. She said “ well I can give you drugs if that’s what you want” but it’s not what I want. Said the scleritis and uveitis could be a fluke
Thank you, I’m coping the best I can… on 8/11 I woke & out of nowhere, I couldn’t see out of my left eye at all. I was rushed to a retina specialist, they diagnosed me with ‘idiopathic posterior uveitis’. It’s been 3months of hell dealing wit. 😓Thanks love. 😘
November 2, 2026 at 4:09 AM
Thank you, I’m coping the best I can… on 8/11 I woke & out of nowhere, I couldn’t see out of my left eye at all. I was rushed to a retina specialist, they diagnosed me with ‘idiopathic posterior uveitis’. It’s been 3months of hell dealing wit. 😓Thanks love. 😘
Ophthopedia Update: Brepocitinib in Patients with Active Noninfectious Uveitis: Results from the Phase 2 NEPTUNE Trial: Publication date: Available online 2 November 2026
Source: AJO International
Author(s): Quan Dong Nguyen, Mark Dacey, Robert Wang, Dilraj S.… #Ophthalmology #AJOInternational
Source: AJO International
Author(s): Quan Dong Nguyen, Mark Dacey, Robert Wang, Dilraj S.… #Ophthalmology #AJOInternational
Brepocitinib in Patients with Active Noninfectious Uveitis: Results from the Phase 2 NEPTUNE Trial
Publication date: Available online 2 November 2026
Source: AJO International
Author(s): Quan Dong Nguyen, Mark Dacey, Robert Wang, Dilraj S. Grewal, Kelly L. Larkin, Edmund Tsui, Akshay Thomas, Christopher R. Henry, David S. Chu, Steven Yeh, Stephen Anesi, James T. Walsh, Lynn M. Hassman, Rajiv Shah, Payam Amini, Robert C. Kwun, Albert Edwards, Veena Raiji, Ana Suelves Cogollos, Brian C. Toy
dlvr.it
November 3, 2026 at 9:16 AM
Ophthopedia Update: Brepocitinib in Patients with Active Noninfectious Uveitis: Results from the Phase 2 NEPTUNE Trial: Publication date: Available online 2 November 2026
Source: AJO International
Author(s): Quan Dong Nguyen, Mark Dacey, Robert Wang, Dilraj S.… #Ophthalmology #AJOInternational
Source: AJO International
Author(s): Quan Dong Nguyen, Mark Dacey, Robert Wang, Dilraj S.… #Ophthalmology #AJOInternational
Ophthopedia Update: Short-term Risk of Inflammatory Eye Reactions Following Bisphosphonate Use: A nationwide case–case–time–control study: To evaluate short-term associations between bisphosphonate exposure and uveitis, scleritis, and cystoid macular edema… #Ophthalmology #ophthotwitter #eyecare
Short-term Risk of Inflammatory Eye Reactions Following Bisphosphonate Use: A nationwide case–case–time–control study
To evaluate short-term associations between bisphosphonate exposure and uveitis, scleritis, and cystoid macular edema (CME).
dlvr.it
November 4, 2026 at 4:22 PM
Ophthopedia Update: Short-term Risk of Inflammatory Eye Reactions Following Bisphosphonate Use: A nationwide case–case–time–control study: To evaluate short-term associations between bisphosphonate exposure and uveitis, scleritis, and cystoid macular edema… #Ophthalmology #ophthotwitter #eyecare
It is wild that during the first COVID wave, I got a blur spot that I thought was PVD, and it took forever to identify that I actually had uveitis that had killed a patch of retinal cells! My auto-immune disorder crept into my eye.
Glad you're on top of your condition hopefully.
Glad you're on top of your condition hopefully.
November 2, 2026 at 1:02 AM
It is wild that during the first COVID wave, I got a blur spot that I thought was PVD, and it took forever to identify that I actually had uveitis that had killed a patch of retinal cells! My auto-immune disorder crept into my eye.
Glad you're on top of your condition hopefully.
Glad you're on top of your condition hopefully.
eye with the initial problem seemed to be on the mend. he had to be tested for FIV and FeLV, but thankfully those were negative. we still aren’t really sure what caused the uveitis, but he seems to be recovering and feeling better after a brief time on pain meds and ongoing eye drops.
November 1, 2026 at 5:56 PM
eye with the initial problem seemed to be on the mend. he had to be tested for FIV and FeLV, but thankfully those were negative. we still aren’t really sure what caused the uveitis, but he seems to be recovering and feeling better after a brief time on pain meds and ongoing eye drops.
Ophthopedia Update: Association Between Circadian Rhythm Sleep Disorder and Noninfectious Uveitis: A Retrospective Cohort Study: .
Association Between Circadian Rhythm Sleep Disorder and Noninfectious Uveitis: A Retrospective Cohort Study
.
dlvr.it
October 30, 2026 at 7:26 PM
Ophthopedia Update: Association Between Circadian Rhythm Sleep Disorder and Noninfectious Uveitis: A Retrospective Cohort Study: .
Ophthopedia Update: Weekly Journal Update — November 4, 2026: Contrast sensitivity differs by AMD stage, statin intensity and risk of noninfectious uveitis, safety study of voretigene neparvovec-rzyl, validation study of FIRST-ROP screening algorithm, VR binocular treatment… #Ophthalmology #News
Weekly Journal Update — November 4, 2026
Contrast sensitivity differs by AMD stage, statin intensity and risk of noninfectious uveitis, safety study of voretigene neparvovec-rzyl, validation study of FIRST-ROP screening algorithm, VR binocular treatment for amblyopia.
dlvr.it
November 4, 2026 at 6:59 PM
Ophthopedia Update: Weekly Journal Update — November 4, 2026: Contrast sensitivity differs by AMD stage, statin intensity and risk of noninfectious uveitis, safety study of voretigene neparvovec-rzyl, validation study of FIRST-ROP screening algorithm, VR binocular treatment… #Ophthalmology #News
that's not cool
a friend of mine has uveitis and has to get shots in his eye which I thought was terrible but this sounds... maybe worse? hate this for you
a friend of mine has uveitis and has to get shots in his eye which I thought was terrible but this sounds... maybe worse? hate this for you
October 31, 2026 at 3:25 AM
that's not cool
a friend of mine has uveitis and has to get shots in his eye which I thought was terrible but this sounds... maybe worse? hate this for you
a friend of mine has uveitis and has to get shots in his eye which I thought was terrible but this sounds... maybe worse? hate this for you
A sight-saving collaboration! The Combined Rheumatology and Ophthalmology Uveitis Clinic, led by DoM’s rheumatologist Dr. Lilia Olaru and ophthalmologist Dr. Matthew Tennant, is improving access to specialized care for patients across Alberta, B.C. and the N.W.T.: www.ualberta.ca/en/folio/202...
Sight-saving clinic improves access to care for patients from Alberta, B.C. and N.W.T.
A unique interdisciplinary clinic is improving access to care for patients with the rare eye condition uveitis.
www.ualberta.ca
November 3, 2026 at 9:31 PM
A sight-saving collaboration! The Combined Rheumatology and Ophthalmology Uveitis Clinic, led by DoM’s rheumatologist Dr. Lilia Olaru and ophthalmologist Dr. Matthew Tennant, is improving access to specialized care for patients across Alberta, B.C. and the N.W.T.: www.ualberta.ca/en/folio/202...
Equine recurrent uveitis is the leading cause of blindness in horses. Join this session to discuss novel therapies, including low-dose intravitreal gentamicin injections, suprachoroidal cyclosporine implants, and suprachoroidal triamcinolone injections. https://bit.ly/4f4OTSD
November 3, 2026 at 11:06 PM
Equine recurrent uveitis is the leading cause of blindness in horses. Join this session to discuss novel therapies, including low-dose intravitreal gentamicin injections, suprachoroidal cyclosporine implants, and suprachoroidal triamcinolone injections. https://bit.ly/4f4OTSD
Ophthopedia Update: Reply to Comment on: Incidence, Prevalence, and Clinical Associations of Non-Infectious Pediatric Uveitis in the United States: A TriNetX Database Study: To the Editor: #Ophthalmology #Ophthotwitter #Scicomm
Reply to Comment on: Incidence, Prevalence, and Clinical Associations of Non-Infectious Pediatric Uveitis in the United States: A TriNetX Database Study
To the Editor:
dlvr.it
October 31, 2026 at 7:18 AM
Ophthopedia Update: Reply to Comment on: Incidence, Prevalence, and Clinical Associations of Non-Infectious Pediatric Uveitis in the United States: A TriNetX Database Study: To the Editor: #Ophthalmology #Ophthotwitter #Scicomm
Ophthopedia Update: Comparative Outcomes of Systemic Immunomodulatory Therapy Versus Local Corticosteroid Therapy in Chronic Noninfectious Uveitis: .
Comparative Outcomes of Systemic Immunomodulatory Therapy Versus Local Corticosteroid Therapy in Chronic Noninfectious Uveitis
.
dlvr.it
October 29, 2026 at 7:25 PM
Ophthopedia Update: Comparative Outcomes of Systemic Immunomodulatory Therapy Versus Local Corticosteroid Therapy in Chronic Noninfectious Uveitis: .
Experience in #Uveitis should deepen our curiosity & humility-familiar patterns help, but every patient can challenge what we think we know
Dr Gupta highlights that listening, revisiting assumptions & knowing when to ask colleagues are skills we dont finish learning
www.threads.com/@iusg.offici...
Dr Gupta highlights that listening, revisiting assumptions & knowing when to ask colleagues are skills we dont finish learning
www.threads.com/@iusg.offici...
IUSG (@iusg.official) on Threads
This week’s Sunday Musings comes from Prof. Dr. Amod Gupta, Emeritus Professor at PGI Chandigarh.
Swipe through for his five lessons and share this with others. We’d like to hear which one stays with...
www.threads.com
November 2, 2026 at 8:36 PM
Experience in #Uveitis should deepen our curiosity & humility-familiar patterns help, but every patient can challenge what we think we know
Dr Gupta highlights that listening, revisiting assumptions & knowing when to ask colleagues are skills we dont finish learning
www.threads.com/@iusg.offici...
Dr Gupta highlights that listening, revisiting assumptions & knowing when to ask colleagues are skills we dont finish learning
www.threads.com/@iusg.offici...
4 años buscando problemas relacionados con la gota. Los análisis daban perfecto el ácido úrico, pero ellos buscaban gota.
Si no llega a ser por la uveítis y el especialista que me vio y la conectó con la artritis, todavía seguirían buscando gota.
Si no llega a ser por la uveítis y el especialista que me vio y la conectó con la artritis, todavía seguirían buscando gota.
October 29, 2026 at 10:09 AM
4 años buscando problemas relacionados con la gota. Los análisis daban perfecto el ácido úrico, pero ellos buscaban gota.
Si no llega a ser por la uveítis y el especialista que me vio y la conectó con la artritis, todavía seguirían buscando gota.
Si no llega a ser por la uveítis y el especialista que me vio y la conectó con la artritis, todavía seguirían buscando gota.
Ophthopedia Update: Comment on:Incidence, Prevalence, and Clinical Associations of Non-Infectious Pediatric Uveitis in the United States: A TriNetX Database Study: Nijim et al reported that the annual incidence of pediatric noninfectious uveitis in TriNetX… #Ophthalmology #Ophthotwitter #Scicomm
Comment on:Incidence, Prevalence, and Clinical Associations of Non-Infectious Pediatric Uveitis in the United States: A TriNetX Database Study
Nijim et al reported that the annual incidence of pediatric noninfectious uveitis in TriNetX increased from 22 to 33 per 100,000 people between 2016 and 2025, and concluded that both incidence and prevalence rose over the decade1. The central validity question is not whether case detection improved, but rather whether disease incidence can be identified from records with patient-specific and potentially evolving observation histories.
dlvr.it
October 30, 2026 at 1:18 PM
Ophthopedia Update: Comment on:Incidence, Prevalence, and Clinical Associations of Non-Infectious Pediatric Uveitis in the United States: A TriNetX Database Study: Nijim et al reported that the annual incidence of pediatric noninfectious uveitis in TriNetX… #Ophthalmology #Ophthotwitter #Scicomm
Ophthopedia Update: Effectiveness and Safety Outcomes After Switching from Reference Biologics to Biosimilars for Treatment of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis #Ophthomology #Eye #Ophthotwitter
Effectiveness and Safety of Switch from Reference Biologics to Biosimi | OPTH | Dove Medical Press
Currently, the available evidence is of low quality and demonstrates insufficient support for a meaningful difference in terms of effectiveness and safety
dlvr.it
November 3, 2026 at 6:22 AM
Ophthopedia Update: Effectiveness and Safety Outcomes After Switching from Reference Biologics to Biosimilars for Treatment of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis #Ophthomology #Eye #Ophthotwitter
JAMA Uveitis review: Uveitis peaks at 20–50 yrs; 41–60% is anterior. ~40 linked to systemic disease (HLA-B27=axSpA). 1st exclude infection (TB, toxo, herpes). Anterior UV: topical steroids. Posterior/pan UV: DMARDs first (MTX remission 52%, MMF 71%); adalimumab if refractory buff.ly/uWveWTw
Uveitis in Adults: A Review
This narrative review summarizes current evidence on the pathophysiology, epidemiology, diagnosis, and treatment of uveitis in adults.
buff.ly
October 26, 2026 at 10:07 PM
JAMA Uveitis review: Uveitis peaks at 20–50 yrs; 41–60% is anterior. ~40 linked to systemic disease (HLA-B27=axSpA). 1st exclude infection (TB, toxo, herpes). Anterior UV: topical steroids. Posterior/pan UV: DMARDs first (MTX remission 52%, MMF 71%); adalimumab if refractory buff.ly/uWveWTw
Star 268397
Listed TBK 10/27
#NYCACC #RescueOnly
She is an 11.6 lb, 12 yr old
Has neuro disease affecting her balance and uveitis R eye and 🚑
Fearful but solicits attention during med exams
Help save Star!
nycacc.app/browse/268397
#Pledge4Medical #foster #adopt
Listed TBK 10/27
#NYCACC #RescueOnly
She is an 11.6 lb, 12 yr old
Has neuro disease affecting her balance and uveitis R eye and 🚑
Fearful but solicits attention during med exams
Help save Star!
nycacc.app/browse/268397
#Pledge4Medical #foster #adopt
October 25, 2026 at 7:18 PM
Star 268397
Listed TBK 10/27
#NYCACC #RescueOnly
She is an 11.6 lb, 12 yr old
Has neuro disease affecting her balance and uveitis R eye and 🚑
Fearful but solicits attention during med exams
Help save Star!
nycacc.app/browse/268397
#Pledge4Medical #foster #adopt
Listed TBK 10/27
#NYCACC #RescueOnly
She is an 11.6 lb, 12 yr old
Has neuro disease affecting her balance and uveitis R eye and 🚑
Fearful but solicits attention during med exams
Help save Star!
nycacc.app/browse/268397
#Pledge4Medical #foster #adopt
Prospective study of children with JIA at risk for or with confirmed uveitis assessed trajectories based on tear-based biomarker levels.
Changes in MCP-1, CXCL10 and IL-8 profiles measured in tear fluid were able to differentiate children with JIA by uveitis diagnosis
AC&R
doi.org/10.1002/acr....
Changes in MCP-1, CXCL10 and IL-8 profiles measured in tear fluid were able to differentiate children with JIA by uveitis diagnosis
AC&R
doi.org/10.1002/acr....
October 26, 2026 at 12:05 PM
Prospective study of children with JIA at risk for or with confirmed uveitis assessed trajectories based on tear-based biomarker levels.
Changes in MCP-1, CXCL10 and IL-8 profiles measured in tear fluid were able to differentiate children with JIA by uveitis diagnosis
AC&R
doi.org/10.1002/acr....
Changes in MCP-1, CXCL10 and IL-8 profiles measured in tear fluid were able to differentiate children with JIA by uveitis diagnosis
AC&R
doi.org/10.1002/acr....